Upgrade to SI Premium - Free Trial

Surgery Partners (SGRY) PT Lowered to $31 at Barclays

November 13, 2024 9:44 AM
Barclays analyst Andrew Mok lowered the price target on Surgery Partners (NASDAQ: SGRY) to $31.00 (from $32.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles